Published in Heart Rhythm on May 02, 2014
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (1999) 10.17
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med (2004) 10.02
Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med (2012) 8.84
Sudden cardiac death in the United States, 1989 to 1998. Circulation (2001) 7.92
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med (2004) 7.12
Defibrillator implantation early after myocardial infarction. N Engl J Med (2009) 5.25
Racial differences in the incidence of cardiac arrest and subsequent survival. The CPR Chicago Project. N Engl J Med (1993) 4.97
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA (2007) 4.89
Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol (2007) 2.15
Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. Heart Rhythm (2009) 1.53
Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study. Heart Rhythm (2011) 1.47
Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest. Circulation (2003) 1.45
Out-of-hospital cardiac arrest: racial differences in outcome in Seattle. Am J Public Health (1993) 1.37
Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description. J Am Heart Assoc (2013) 1.30
Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of <or=35%. Am J Cardiol (2007) 1.17
Effectiveness of the implantable cardioverter defibrillator in blacks versus whites (from MADIT-II). Am J Cardiol (2006) 1.01
Racial differences in outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT): a comparison of whites versus blacks. Circulation (2003) 1.00
Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J (2007) 0.98
The effect of comorbidity on the competing risk of sudden and nonsudden death in an ambulatory heart failure population. Can J Cardiol (2011) 0.94
Racial differences in out-of-hospital cardiac arrest survival and treatment. Emerg Med J (2011) 0.88
The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality. Europace (2010) 0.83
Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients. J Am Coll Cardiol (2015) 1.43
Clinical and serum-based markers are associated with death within 1 year of de novo implant in primary prevention ICD recipients. Heart Rhythm (2014) 0.76
Clinical Inferences of Cardiovascular Implantable Electronic Device Analysis at Autopsy. J Am Coll Cardiol (2016) 0.76
Cardiovascular implantable electronic device function and longevity at autopsy: an underestimated resource. Heart Rhythm (2016) 0.75
Association of Mitochondrial DNA Copy Number With Cardiovascular Disease. JAMA Cardiol (2017) 0.75